nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Insomnia—Valsartan—coronary artery disease	0.000697	0.00124	CcSEcCtD
Fenoldopam—Tachycardia—Enalapril—coronary artery disease	0.000697	0.00124	CcSEcCtD
Fenoldopam—Nausea—Gemfibrozil—coronary artery disease	0.000696	0.00123	CcSEcCtD
Fenoldopam—Bradycardia—Lisinopril—coronary artery disease	0.000695	0.00123	CcSEcCtD
Fenoldopam—Abdominal pain—Clopidogrel—coronary artery disease	0.000695	0.00123	CcSEcCtD
Fenoldopam—Body temperature increased—Clopidogrel—coronary artery disease	0.000695	0.00123	CcSEcCtD
Fenoldopam—Insomnia—Olmesartan—coronary artery disease	0.000694	0.00123	CcSEcCtD
Fenoldopam—Chest pain—Perindopril—coronary artery disease	0.000694	0.00123	CcSEcCtD
Fenoldopam—Hyperhidrosis—Trandolapril—coronary artery disease	0.000693	0.00123	CcSEcCtD
Fenoldopam—Anxiety—Perindopril—coronary artery disease	0.000691	0.00123	CcSEcCtD
Fenoldopam—Hyperhidrosis—Enalapril—coronary artery disease	0.00069	0.00122	CcSEcCtD
Fenoldopam—Body temperature increased—Lovastatin—coronary artery disease	0.00069	0.00122	CcSEcCtD
Fenoldopam—Abdominal pain—Lovastatin—coronary artery disease	0.00069	0.00122	CcSEcCtD
Fenoldopam—Dyspnoea—Valsartan—coronary artery disease	0.000688	0.00122	CcSEcCtD
Fenoldopam—Tachycardia—Telmisartan—coronary artery disease	0.000687	0.00122	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000685	0.00122	CcSEcCtD
Fenoldopam—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000685	0.00121	CcSEcCtD
Fenoldopam—Dizziness—Rosuvastatin—coronary artery disease	0.000681	0.00121	CcSEcCtD
Fenoldopam—Hyperhidrosis—Telmisartan—coronary artery disease	0.000681	0.00121	CcSEcCtD
Fenoldopam—Nausea—Ticagrelor—coronary artery disease	0.00068	0.00121	CcSEcCtD
Fenoldopam—Insomnia—Niacin—coronary artery disease	0.000678	0.0012	CcSEcCtD
Fenoldopam—Abdominal pain—Ezetimibe—coronary artery disease	0.000677	0.0012	CcSEcCtD
Fenoldopam—Body temperature increased—Ezetimibe—coronary artery disease	0.000677	0.0012	CcSEcCtD
Fenoldopam—Palpitations—Losartan—coronary artery disease	0.000675	0.0012	CcSEcCtD
Fenoldopam—Hypotension—Trandolapril—coronary artery disease	0.00067	0.00119	CcSEcCtD
Fenoldopam—Dyspnoea—Niacin—coronary artery disease	0.000668	0.00119	CcSEcCtD
Fenoldopam—Tachycardia—Captopril—coronary artery disease	0.000668	0.00119	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000668	0.00118	CcSEcCtD
Fenoldopam—Insomnia—Pravastatin—coronary artery disease	0.000668	0.00118	CcSEcCtD
Fenoldopam—Hypotension—Enalapril—coronary artery disease	0.000667	0.00118	CcSEcCtD
Fenoldopam—Abdominal pain—Eplerenone—coronary artery disease	0.000663	0.00118	CcSEcCtD
Fenoldopam—Body temperature increased—Eplerenone—coronary artery disease	0.000663	0.00118	CcSEcCtD
Fenoldopam—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000662	0.00117	CcSEcCtD
Fenoldopam—Constipation—Valsartan—coronary artery disease	0.000659	0.00117	CcSEcCtD
Fenoldopam—Dyspnoea—Pravastatin—coronary artery disease	0.000658	0.00117	CcSEcCtD
Fenoldopam—Hypotension—Telmisartan—coronary artery disease	0.000658	0.00117	CcSEcCtD
Fenoldopam—Constipation—Olmesartan—coronary artery disease	0.000656	0.00116	CcSEcCtD
Fenoldopam—Chest pain—Losartan—coronary artery disease	0.000651	0.00115	CcSEcCtD
Fenoldopam—Tachycardia—Perindopril—coronary artery disease	0.000649	0.00115	CcSEcCtD
Fenoldopam—Insomnia—Trandolapril—coronary artery disease	0.000648	0.00115	CcSEcCtD
Fenoldopam—Anxiety—Losartan—coronary artery disease	0.000648	0.00115	CcSEcCtD
Fenoldopam—Insomnia—Enalapril—coronary artery disease	0.000646	0.00115	CcSEcCtD
Fenoldopam—Body temperature increased—Simvastatin—coronary artery disease	0.000646	0.00115	CcSEcCtD
Fenoldopam—Abdominal pain—Simvastatin—coronary artery disease	0.000646	0.00115	CcSEcCtD
Fenoldopam—Headache—Rosuvastatin—coronary artery disease	0.000645	0.00114	CcSEcCtD
Fenoldopam—Tension—Ramipril—coronary artery disease	0.000643	0.00114	CcSEcCtD
Fenoldopam—Hyperhidrosis—Perindopril—coronary artery disease	0.000643	0.00114	CcSEcCtD
Fenoldopam—Hypotension—Captopril—coronary artery disease	0.00064	0.00114	CcSEcCtD
Fenoldopam—Dyspnoea—Trandolapril—coronary artery disease	0.000639	0.00113	CcSEcCtD
Fenoldopam—Insomnia—Telmisartan—coronary artery disease	0.000637	0.00113	CcSEcCtD
Fenoldopam—Dyspnoea—Enalapril—coronary artery disease	0.000637	0.00113	CcSEcCtD
Fenoldopam—Nervousness—Ramipril—coronary artery disease	0.000636	0.00113	CcSEcCtD
Fenoldopam—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000636	0.00113	CcSEcCtD
Fenoldopam—Flushing—Lisinopril—coronary artery disease	0.000634	0.00112	CcSEcCtD
Fenoldopam—Constipation—Pravastatin—coronary artery disease	0.000631	0.00112	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Valsartan—coronary artery disease	0.000631	0.00112	CcSEcCtD
Fenoldopam—Muscle spasms—Ramipril—coronary artery disease	0.00063	0.00112	CcSEcCtD
Fenoldopam—Tension—Timolol—coronary artery disease	0.000629	0.00112	CcSEcCtD
Fenoldopam—Dyspnoea—Telmisartan—coronary artery disease	0.000628	0.00111	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000628	0.00111	CcSEcCtD
Fenoldopam—Hyperhidrosis—Furosemide—coronary artery disease	0.000625	0.00111	CcSEcCtD
Fenoldopam—Nervousness—Timolol—coronary artery disease	0.000622	0.0011	CcSEcCtD
Fenoldopam—Hypotension—Perindopril—coronary artery disease	0.000621	0.0011	CcSEcCtD
Fenoldopam—Insomnia—Captopril—coronary artery disease	0.000619	0.0011	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Niacin—coronary artery disease	0.000613	0.00109	CcSEcCtD
Fenoldopam—Constipation—Trandolapril—coronary artery disease	0.000613	0.00109	CcSEcCtD
Fenoldopam—Nausea—Rosuvastatin—coronary artery disease	0.000612	0.00109	CcSEcCtD
Fenoldopam—Diarrhoea—Fenofibrate—coronary artery disease	0.000612	0.00109	CcSEcCtD
Fenoldopam—Constipation—Enalapril—coronary artery disease	0.000611	0.00108	CcSEcCtD
Fenoldopam—Dyspnoea—Captopril—coronary artery disease	0.000611	0.00108	CcSEcCtD
Fenoldopam—Abdominal pain—Valsartan—coronary artery disease	0.00061	0.00108	CcSEcCtD
Fenoldopam—Tachycardia—Losartan—coronary artery disease	0.000609	0.00108	CcSEcCtD
Fenoldopam—Abdominal pain—Olmesartan—coronary artery disease	0.000607	0.00108	CcSEcCtD
Fenoldopam—Body temperature increased—Olmesartan—coronary artery disease	0.000607	0.00108	CcSEcCtD
Fenoldopam—Hypotension—Furosemide—coronary artery disease	0.000604	0.00107	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000604	0.00107	CcSEcCtD
Fenoldopam—Hyperhidrosis—Losartan—coronary artery disease	0.000603	0.00107	CcSEcCtD
Fenoldopam—Constipation—Telmisartan—coronary artery disease	0.000602	0.00107	CcSEcCtD
Fenoldopam—Insomnia—Perindopril—coronary artery disease	0.000601	0.00107	CcSEcCtD
Fenoldopam—Diarrhoea—Clopidogrel—coronary artery disease	0.000601	0.00107	CcSEcCtD
Fenoldopam—Diarrhoea—Lovastatin—coronary artery disease	0.000597	0.00106	CcSEcCtD
Fenoldopam—Nausea—Acetylsalicylic acid—coronary artery disease	0.000594	0.00105	CcSEcCtD
Fenoldopam—Dyspnoea—Perindopril—coronary artery disease	0.000593	0.00105	CcSEcCtD
Fenoldopam—Abdominal pain—Niacin—coronary artery disease	0.000593	0.00105	CcSEcCtD
Fenoldopam—Body temperature increased—Niacin—coronary artery disease	0.000593	0.00105	CcSEcCtD
Fenoldopam—Dizziness—Fenofibrate—coronary artery disease	0.000591	0.00105	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000586	0.00104	CcSEcCtD
Fenoldopam—Diarrhoea—Ezetimibe—coronary artery disease	0.000586	0.00104	CcSEcCtD
Fenoldopam—Constipation—Captopril—coronary artery disease	0.000586	0.00104	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Enalapril—coronary artery disease	0.000584	0.00104	CcSEcCtD
Fenoldopam—Abdominal pain—Pravastatin—coronary artery disease	0.000584	0.00104	CcSEcCtD
Fenoldopam—Body temperature increased—Pravastatin—coronary artery disease	0.000584	0.00104	CcSEcCtD
Fenoldopam—Tension—Lisinopril—coronary artery disease	0.000583	0.00103	CcSEcCtD
Fenoldopam—Hypotension—Losartan—coronary artery disease	0.000583	0.00103	CcSEcCtD
Fenoldopam—Dizziness—Clopidogrel—coronary artery disease	0.000581	0.00103	CcSEcCtD
Fenoldopam—Palpitations—Ramipril—coronary artery disease	0.000579	0.00103	CcSEcCtD
Fenoldopam—Dizziness—Lovastatin—coronary artery disease	0.000577	0.00102	CcSEcCtD
Fenoldopam—Nervousness—Lisinopril—coronary artery disease	0.000577	0.00102	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000576	0.00102	CcSEcCtD
Fenoldopam—Back pain—Lisinopril—coronary artery disease	0.000575	0.00102	CcSEcCtD
Fenoldopam—Diarrhoea—Eplerenone—coronary artery disease	0.000573	0.00102	CcSEcCtD
Fenoldopam—Muscle spasms—Lisinopril—coronary artery disease	0.000571	0.00101	CcSEcCtD
Fenoldopam—Constipation—Perindopril—coronary artery disease	0.000569	0.00101	CcSEcCtD
Fenoldopam—Vomiting—Fenofibrate—coronary artery disease	0.000568	0.00101	CcSEcCtD
Fenoldopam—Body temperature increased—Trandolapril—coronary artery disease	0.000567	0.00101	CcSEcCtD
Fenoldopam—Abdominal pain—Trandolapril—coronary artery disease	0.000567	0.00101	CcSEcCtD
Fenoldopam—Dizziness—Ezetimibe—coronary artery disease	0.000566	0.001	CcSEcCtD
Fenoldopam—Palpitations—Timolol—coronary artery disease	0.000566	0.001	CcSEcCtD
Fenoldopam—Abdominal pain—Enalapril—coronary artery disease	0.000564	0.001	CcSEcCtD
Fenoldopam—Body temperature increased—Enalapril—coronary artery disease	0.000564	0.001	CcSEcCtD
Fenoldopam—Insomnia—Losartan—coronary artery disease	0.000564	0.001	CcSEcCtD
Fenoldopam—Headache—Fenofibrate—coronary artery disease	0.00056	0.000993	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Captopril—coronary artery disease	0.00056	0.000993	CcSEcCtD
Fenoldopam—Vomiting—Clopidogrel—coronary artery disease	0.000559	0.000991	CcSEcCtD
Fenoldopam—Diarrhoea—Simvastatin—coronary artery disease	0.000559	0.000991	CcSEcCtD
Fenoldopam—Chest pain—Ramipril—coronary artery disease	0.000558	0.00099	CcSEcCtD
Fenoldopam—Abdominal pain—Telmisartan—coronary artery disease	0.000557	0.000988	CcSEcCtD
Fenoldopam—Body temperature increased—Telmisartan—coronary artery disease	0.000557	0.000988	CcSEcCtD
Fenoldopam—Dyspnoea—Losartan—coronary artery disease	0.000556	0.000986	CcSEcCtD
Fenoldopam—Anxiety—Ramipril—coronary artery disease	0.000556	0.000986	CcSEcCtD
Fenoldopam—Vomiting—Lovastatin—coronary artery disease	0.000555	0.000985	CcSEcCtD
Fenoldopam—Dizziness—Eplerenone—coronary artery disease	0.000554	0.000983	CcSEcCtD
Fenoldopam—Constipation—Furosemide—coronary artery disease	0.000553	0.00098	CcSEcCtD
Fenoldopam—Headache—Clopidogrel—coronary artery disease	0.000551	0.000977	CcSEcCtD
Fenoldopam—Headache—Lovastatin—coronary artery disease	0.000547	0.00097	CcSEcCtD
Fenoldopam—Chest pain—Timolol—coronary artery disease	0.000545	0.000967	CcSEcCtD
Fenoldopam—Vomiting—Ezetimibe—coronary artery disease	0.000544	0.000966	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Perindopril—coronary artery disease	0.000544	0.000964	CcSEcCtD
Fenoldopam—Anxiety—Timolol—coronary artery disease	0.000543	0.000964	CcSEcCtD
Fenoldopam—Abdominal pain—Captopril—coronary artery disease	0.000541	0.00096	CcSEcCtD
Fenoldopam—Body temperature increased—Captopril—coronary artery disease	0.000541	0.00096	CcSEcCtD
Fenoldopam—Dizziness—Simvastatin—coronary artery disease	0.00054	0.000958	CcSEcCtD
Fenoldopam—Headache—Ezetimibe—coronary artery disease	0.000536	0.000951	CcSEcCtD
Fenoldopam—Constipation—Losartan—coronary artery disease	0.000533	0.000946	CcSEcCtD
Fenoldopam—Vomiting—Eplerenone—coronary artery disease	0.000533	0.000945	CcSEcCtD
Fenoldopam—Nausea—Fenofibrate—coronary artery disease	0.000531	0.000942	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Furosemide—coronary artery disease	0.000529	0.000938	CcSEcCtD
Fenoldopam—Diarrhoea—Valsartan—coronary artery disease	0.000528	0.000936	CcSEcCtD
Fenoldopam—Abdominal pain—Perindopril—coronary artery disease	0.000526	0.000932	CcSEcCtD
Fenoldopam—Body temperature increased—Perindopril—coronary artery disease	0.000526	0.000932	CcSEcCtD
Fenoldopam—Palpitations—Lisinopril—coronary artery disease	0.000525	0.000932	CcSEcCtD
Fenoldopam—Diarrhoea—Olmesartan—coronary artery disease	0.000525	0.000931	CcSEcCtD
Fenoldopam—Headache—Eplerenone—coronary artery disease	0.000525	0.000931	CcSEcCtD
Fenoldopam—Nausea—Clopidogrel—coronary artery disease	0.000522	0.000926	CcSEcCtD
Fenoldopam—Tachycardia—Ramipril—coronary artery disease	0.000522	0.000926	CcSEcCtD
Fenoldopam—Vomiting—Simvastatin—coronary artery disease	0.000519	0.000921	CcSEcCtD
Fenoldopam—Nausea—Lovastatin—coronary artery disease	0.000519	0.00092	CcSEcCtD
Fenoldopam—Hyperhidrosis—Ramipril—coronary artery disease	0.000517	0.000917	CcSEcCtD
Fenoldopam—Diarrhoea—Niacin—coronary artery disease	0.000513	0.00091	CcSEcCtD
Fenoldopam—Headache—Simvastatin—coronary artery disease	0.000512	0.000907	CcSEcCtD
Fenoldopam—Abdominal pain—Furosemide—coronary artery disease	0.000511	0.000906	CcSEcCtD
Fenoldopam—Body temperature increased—Furosemide—coronary artery disease	0.000511	0.000906	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Losartan—coronary artery disease	0.00051	0.000905	CcSEcCtD
Fenoldopam—Dizziness—Valsartan—coronary artery disease	0.00051	0.000905	CcSEcCtD
Fenoldopam—Nausea—Ezetimibe—coronary artery disease	0.000509	0.000902	CcSEcCtD
Fenoldopam—Dizziness—Olmesartan—coronary artery disease	0.000507	0.0009	CcSEcCtD
Fenoldopam—Chest pain—Lisinopril—coronary artery disease	0.000506	0.000897	CcSEcCtD
Fenoldopam—Hyperhidrosis—Timolol—coronary artery disease	0.000505	0.000896	CcSEcCtD
Fenoldopam—Diarrhoea—Pravastatin—coronary artery disease	0.000505	0.000896	CcSEcCtD
Fenoldopam—Anxiety—Lisinopril—coronary artery disease	0.000504	0.000894	CcSEcCtD
Fenoldopam—Hypotension—Ramipril—coronary artery disease	0.0005	0.000886	CcSEcCtD
Fenoldopam—Nausea—Eplerenone—coronary artery disease	0.000498	0.000883	CcSEcCtD
Fenoldopam—Dizziness—Niacin—coronary artery disease	0.000496	0.000879	CcSEcCtD
Fenoldopam—Abdominal pain—Losartan—coronary artery disease	0.000493	0.000875	CcSEcCtD
Fenoldopam—Body temperature increased—Losartan—coronary artery disease	0.000493	0.000875	CcSEcCtD
Fenoldopam—Diarrhoea—Trandolapril—coronary artery disease	0.000491	0.00087	CcSEcCtD
Fenoldopam—Vomiting—Valsartan—coronary artery disease	0.00049	0.00087	CcSEcCtD
Fenoldopam—Diarrhoea—Enalapril—coronary artery disease	0.000489	0.000867	CcSEcCtD
Fenoldopam—Hypotension—Timolol—coronary artery disease	0.000489	0.000867	CcSEcCtD
Fenoldopam—Dizziness—Pravastatin—coronary artery disease	0.000488	0.000866	CcSEcCtD
Fenoldopam—Vomiting—Olmesartan—coronary artery disease	0.000488	0.000866	CcSEcCtD
Fenoldopam—Nausea—Simvastatin—coronary artery disease	0.000485	0.00086	CcSEcCtD
Fenoldopam—Insomnia—Ramipril—coronary artery disease	0.000484	0.000858	CcSEcCtD
Fenoldopam—Headache—Valsartan—coronary artery disease	0.000483	0.000857	CcSEcCtD
Fenoldopam—Diarrhoea—Telmisartan—coronary artery disease	0.000482	0.000855	CcSEcCtD
Fenoldopam—Headache—Olmesartan—coronary artery disease	0.000481	0.000853	CcSEcCtD
Fenoldopam—Dyspnoea—Ramipril—coronary artery disease	0.000477	0.000846	CcSEcCtD
Fenoldopam—Vomiting—Niacin—coronary artery disease	0.000477	0.000846	CcSEcCtD
Fenoldopam—Dizziness—Trandolapril—coronary artery disease	0.000474	0.000841	CcSEcCtD
Fenoldopam—Tachycardia—Lisinopril—coronary artery disease	0.000473	0.00084	CcSEcCtD
Fenoldopam—Insomnia—Timolol—coronary artery disease	0.000473	0.000839	CcSEcCtD
Fenoldopam—Dizziness—Enalapril—coronary artery disease	0.000472	0.000838	CcSEcCtD
Fenoldopam—Headache—Niacin—coronary artery disease	0.00047	0.000833	CcSEcCtD
Fenoldopam—Vomiting—Pravastatin—coronary artery disease	0.000469	0.000833	CcSEcCtD
Fenoldopam—Hyperhidrosis—Lisinopril—coronary artery disease	0.000469	0.000832	CcSEcCtD
Fenoldopam—Diarrhoea—Captopril—coronary artery disease	0.000469	0.000831	CcSEcCtD
Fenoldopam—Dyspnoea—Timolol—coronary artery disease	0.000466	0.000827	CcSEcCtD
Fenoldopam—Dizziness—Telmisartan—coronary artery disease	0.000466	0.000826	CcSEcCtD
Fenoldopam—Headache—Pravastatin—coronary artery disease	0.000462	0.00082	CcSEcCtD
Fenoldopam—Nausea—Valsartan—coronary artery disease	0.000458	0.000812	CcSEcCtD
Fenoldopam—Constipation—Ramipril—coronary artery disease	0.000457	0.000811	CcSEcCtD
Fenoldopam—Nausea—Olmesartan—coronary artery disease	0.000456	0.000809	CcSEcCtD
Fenoldopam—Vomiting—Trandolapril—coronary artery disease	0.000456	0.000809	CcSEcCtD
Fenoldopam—Diarrhoea—Perindopril—coronary artery disease	0.000455	0.000807	CcSEcCtD
Fenoldopam—Vomiting—Enalapril—coronary artery disease	0.000454	0.000805	CcSEcCtD
Fenoldopam—Hypotension—Lisinopril—coronary artery disease	0.000453	0.000804	CcSEcCtD
Fenoldopam—Dizziness—Captopril—coronary artery disease	0.000453	0.000803	CcSEcCtD
Fenoldopam—Headache—Trandolapril—coronary artery disease	0.000449	0.000797	CcSEcCtD
Fenoldopam—Vomiting—Telmisartan—coronary artery disease	0.000448	0.000794	CcSEcCtD
Fenoldopam—Headache—Enalapril—coronary artery disease	0.000447	0.000793	CcSEcCtD
Fenoldopam—Nausea—Niacin—coronary artery disease	0.000445	0.00079	CcSEcCtD
Fenoldopam—Diarrhoea—Furosemide—coronary artery disease	0.000442	0.000784	CcSEcCtD
Fenoldopam—Headache—Telmisartan—coronary artery disease	0.000441	0.000783	CcSEcCtD
Fenoldopam—Dizziness—Perindopril—coronary artery disease	0.00044	0.00078	CcSEcCtD
Fenoldopam—Insomnia—Lisinopril—coronary artery disease	0.000439	0.000778	CcSEcCtD
Fenoldopam—Nausea—Pravastatin—coronary artery disease	0.000439	0.000778	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ramipril—coronary artery disease	0.000437	0.000776	CcSEcCtD
Fenoldopam—Vomiting—Captopril—coronary artery disease	0.000435	0.000772	CcSEcCtD
Fenoldopam—Dyspnoea—Lisinopril—coronary artery disease	0.000432	0.000767	CcSEcCtD
Fenoldopam—Headache—Captopril—coronary artery disease	0.000429	0.000761	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Timolol—coronary artery disease	0.000428	0.000758	CcSEcCtD
Fenoldopam—Dizziness—Furosemide—coronary artery disease	0.000427	0.000758	CcSEcCtD
Fenoldopam—Diarrhoea—Losartan—coronary artery disease	0.000427	0.000757	CcSEcCtD
Fenoldopam—Nausea—Trandolapril—coronary artery disease	0.000426	0.000755	CcSEcCtD
Fenoldopam—Nausea—Enalapril—coronary artery disease	0.000424	0.000752	CcSEcCtD
Fenoldopam—Vomiting—Perindopril—coronary artery disease	0.000423	0.00075	CcSEcCtD
Fenoldopam—Body temperature increased—Ramipril—coronary artery disease	0.000423	0.00075	CcSEcCtD
Fenoldopam—Abdominal pain—Ramipril—coronary artery disease	0.000423	0.00075	CcSEcCtD
Fenoldopam—Nausea—Telmisartan—coronary artery disease	0.000418	0.000742	CcSEcCtD
Fenoldopam—Headache—Perindopril—coronary artery disease	0.000417	0.000739	CcSEcCtD
Fenoldopam—Constipation—Lisinopril—coronary artery disease	0.000415	0.000736	CcSEcCtD
Fenoldopam—Abdominal pain—Timolol—coronary artery disease	0.000413	0.000733	CcSEcCtD
Fenoldopam—Body temperature increased—Timolol—coronary artery disease	0.000413	0.000733	CcSEcCtD
Fenoldopam—Dizziness—Losartan—coronary artery disease	0.000412	0.000732	CcSEcCtD
Fenoldopam—Vomiting—Furosemide—coronary artery disease	0.000411	0.000729	CcSEcCtD
Fenoldopam—Nausea—Captopril—coronary artery disease	0.000407	0.000722	CcSEcCtD
Fenoldopam—Headache—Furosemide—coronary artery disease	0.000405	0.000718	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000397	0.000703	CcSEcCtD
Fenoldopam—Vomiting—Losartan—coronary artery disease	0.000397	0.000703	CcSEcCtD
Fenoldopam—Nausea—Perindopril—coronary artery disease	0.000395	0.000701	CcSEcCtD
Fenoldopam—Headache—Losartan—coronary artery disease	0.000391	0.000693	CcSEcCtD
Fenoldopam—Nausea—Furosemide—coronary artery disease	0.000384	0.000681	CcSEcCtD
Fenoldopam—Abdominal pain—Lisinopril—coronary artery disease	0.000383	0.00068	CcSEcCtD
Fenoldopam—Body temperature increased—Lisinopril—coronary artery disease	0.000383	0.00068	CcSEcCtD
Fenoldopam—Nausea—Losartan—coronary artery disease	0.00037	0.000657	CcSEcCtD
Fenoldopam—Diarrhoea—Ramipril—coronary artery disease	0.000366	0.000649	CcSEcCtD
Fenoldopam—Diarrhoea—Timolol—coronary artery disease	0.000358	0.000634	CcSEcCtD
Fenoldopam—Dizziness—Ramipril—coronary artery disease	0.000354	0.000627	CcSEcCtD
Fenoldopam—Dizziness—Timolol—coronary artery disease	0.000346	0.000613	CcSEcCtD
Fenoldopam—Vomiting—Ramipril—coronary artery disease	0.00034	0.000603	CcSEcCtD
Fenoldopam—Headache—Ramipril—coronary artery disease	0.000335	0.000594	CcSEcCtD
Fenoldopam—Vomiting—Timolol—coronary artery disease	0.000332	0.00059	CcSEcCtD
Fenoldopam—Diarrhoea—Lisinopril—coronary artery disease	0.000332	0.000589	CcSEcCtD
Fenoldopam—Headache—Timolol—coronary artery disease	0.000328	0.000581	CcSEcCtD
Fenoldopam—Dizziness—Lisinopril—coronary artery disease	0.000321	0.000569	CcSEcCtD
Fenoldopam—Nausea—Ramipril—coronary artery disease	0.000318	0.000563	CcSEcCtD
Fenoldopam—Nausea—Timolol—coronary artery disease	0.000311	0.000551	CcSEcCtD
Fenoldopam—Vomiting—Lisinopril—coronary artery disease	0.000308	0.000547	CcSEcCtD
Fenoldopam—Headache—Lisinopril—coronary artery disease	0.000304	0.000539	CcSEcCtD
Fenoldopam—Nausea—Lisinopril—coronary artery disease	0.000288	0.000511	CcSEcCtD
Fenoldopam—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	1.21e-05	2.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	1.21e-05	2.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	1.2e-05	2.76e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—FGF2—coronary artery disease	1.2e-05	2.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	1.2e-05	2.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LEP—coronary artery disease	1.19e-05	2.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOE—coronary artery disease	1.19e-05	2.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KIT—coronary artery disease	1.19e-05	2.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	1.19e-05	2.72e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—coronary artery disease	1.18e-05	2.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	1.18e-05	2.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	1.18e-05	2.71e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOA1—coronary artery disease	1.18e-05	2.71e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—coronary artery disease	1.18e-05	2.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—coronary artery disease	1.18e-05	2.7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	1.18e-05	2.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	1.17e-05	2.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—coronary artery disease	1.17e-05	2.69e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KDR—coronary artery disease	1.17e-05	2.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	1.17e-05	2.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KIT—coronary artery disease	1.17e-05	2.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	1.16e-05	2.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK14—coronary artery disease	1.16e-05	2.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	1.16e-05	2.66e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK1—coronary artery disease	1.16e-05	2.65e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—JAK2—coronary artery disease	1.15e-05	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—coronary artery disease	1.15e-05	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—coronary artery disease	1.15e-05	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	1.15e-05	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—C3—coronary artery disease	1.15e-05	2.63e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ESR1—coronary artery disease	1.14e-05	2.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	1.14e-05	2.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	1.14e-05	2.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	1.14e-05	2.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—coronary artery disease	1.13e-05	2.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	1.13e-05	2.59e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—coronary artery disease	1.13e-05	2.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KDR—coronary artery disease	1.13e-05	2.58e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—F2—coronary artery disease	1.13e-05	2.58e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FN1—coronary artery disease	1.13e-05	2.58e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	1.12e-05	2.57e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6ST—coronary artery disease	1.12e-05	2.57e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	1.12e-05	2.57e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	1.11e-05	2.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—coronary artery disease	1.11e-05	2.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	1.11e-05	2.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—coronary artery disease	1.11e-05	2.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	1.11e-05	2.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.11e-05	2.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	1.11e-05	2.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	1.11e-05	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	1.1e-05	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	1.1e-05	2.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—coronary artery disease	1.1e-05	2.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	1.1e-05	2.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—coronary artery disease	1.09e-05	2.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	1.09e-05	2.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	1.09e-05	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—coronary artery disease	1.09e-05	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	1.09e-05	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FN1—coronary artery disease	1.08e-05	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—F2—coronary artery disease	1.08e-05	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	1.08e-05	2.48e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	1.08e-05	2.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—coronary artery disease	1.08e-05	2.47e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KIT—coronary artery disease	1.08e-05	2.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	1.07e-05	2.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	1.07e-05	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	1.07e-05	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.07e-05	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.07e-05	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	1.07e-05	2.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.06e-05	2.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	1.06e-05	2.42e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL8—coronary artery disease	1.05e-05	2.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.05e-05	2.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.04e-05	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KIT—coronary artery disease	1.04e-05	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	1.04e-05	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.03e-05	2.37e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GSK3B—coronary artery disease	1.03e-05	2.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	1.03e-05	2.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.03e-05	2.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—coronary artery disease	1.03e-05	2.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CREB1—coronary artery disease	1.03e-05	2.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.02e-05	2.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.02e-05	2.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	1.02e-05	2.33e-05	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—coronary artery disease	1.02e-05	2.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.01e-05	2.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.01e-05	2.31e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—coronary artery disease	1.01e-05	2.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.01e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—coronary artery disease	1e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—coronary artery disease	1e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	1e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—coronary artery disease	1e-05	2.3e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6R—coronary artery disease	1e-05	2.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	1e-05	2.29e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—coronary artery disease	9.99e-06	2.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	9.96e-06	2.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	9.96e-06	2.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	9.93e-06	2.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	9.88e-06	2.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—coronary artery disease	9.88e-06	2.27e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—coronary artery disease	9.87e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	9.86e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	9.86e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	9.84e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	9.82e-06	2.25e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—coronary artery disease	9.79e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	9.7e-06	2.22e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	9.67e-06	2.22e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	9.66e-06	2.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KIT—coronary artery disease	9.65e-06	2.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	9.64e-06	2.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	9.58e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—coronary artery disease	9.58e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	9.51e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—coronary artery disease	9.51e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	9.46e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	9.43e-06	2.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	9.39e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	9.38e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	9.38e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	9.37e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	9.36e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	9.26e-06	2.12e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	9.24e-06	2.12e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—coronary artery disease	9.22e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—coronary artery disease	9.18e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	9.18e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	9.1e-06	2.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGF2—coronary artery disease	9.07e-06	2.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	9.04e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	9.04e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	9.03e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	8.99e-06	2.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	8.96e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	8.96e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—coronary artery disease	8.95e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	8.9e-06	2.04e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—coronary artery disease	8.89e-06	2.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	8.83e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	8.79e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—coronary artery disease	8.76e-06	2.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	8.75e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	8.74e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	8.72e-06	2e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JAK2—coronary artery disease	8.69e-06	1.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	8.62e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	8.61e-06	1.97e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—coronary artery disease	8.54e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	8.52e-06	1.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	8.47e-06	1.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	8.45e-06	1.94e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	8.42e-06	1.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	8.4e-06	1.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	8.39e-06	1.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	8.38e-06	1.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	8.37e-06	1.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	8.32e-06	1.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	8.31e-06	1.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	8.24e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	8.21e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	8.21e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—coronary artery disease	8.2e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	8.18e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	8.15e-06	1.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	8.12e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	8.02e-06	1.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	8.01e-06	1.84e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—coronary artery disease	7.94e-06	1.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	7.91e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—coronary artery disease	7.84e-06	1.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	7.79e-06	1.78e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	7.78e-06	1.78e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	7.73e-06	1.77e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK1—coronary artery disease	7.68e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	7.67e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	7.67e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	7.65e-06	1.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	7.63e-06	1.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	7.6e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—coronary artery disease	7.6e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	7.58e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	7.55e-06	1.73e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—coronary artery disease	7.55e-06	1.73e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.39e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	7.39e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	7.32e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	7.27e-06	1.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—coronary artery disease	7.18e-06	1.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	7.12e-06	1.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	7.1e-06	1.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	7.1e-06	1.63e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	6.99e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	6.98e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—coronary artery disease	6.96e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	6.92e-06	1.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	6.86e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	6.84e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	6.8e-06	1.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	6.75e-06	1.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	6.71e-06	1.54e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.67e-06	1.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—coronary artery disease	6.63e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	6.62e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	6.58e-06	1.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	6.52e-06	1.49e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.45e-06	1.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	6.43e-06	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	6.42e-06	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	6.39e-06	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	6.29e-06	1.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	6.23e-06	1.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	6.21e-06	1.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	5.94e-06	1.36e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.92e-06	1.36e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—coronary artery disease	5.9e-06	1.35e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—coronary artery disease	5.83e-06	1.34e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.8e-06	1.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	5.77e-06	1.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	5.7e-06	1.31e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.59e-06	1.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.55e-06	1.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	5.46e-06	1.25e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—coronary artery disease	5.45e-06	1.25e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—coronary artery disease	5.42e-06	1.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—coronary artery disease	5.39e-06	1.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	5.37e-06	1.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	5.3e-06	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—coronary artery disease	5.26e-06	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	5.19e-06	1.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	5.03e-06	1.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—coronary artery disease	4.91e-06	1.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.85e-06	1.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.85e-06	1.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—coronary artery disease	4.84e-06	1.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.53e-06	1.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.51e-06	1.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	4.46e-06	1.02e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—coronary artery disease	4.46e-06	1.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—coronary artery disease	4.4e-06	1.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—coronary artery disease	4.29e-06	9.84e-06	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.11e-06	9.43e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—coronary artery disease	3.99e-06	9.15e-06	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.96e-06	9.08e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.68e-06	8.44e-06	CbGpPWpGaD
